202 related articles for article (PubMed ID: 21707866)
1. Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.
Di Vito M; De Santis E; Perrone GA; Mari E; Giordano MC; De Antoni E; Coppola L; Fadda G; Tafani M; Carpi A; Russo MA
Cancer Sci; 2011 Oct; 102(10):1921-7. PubMed ID: 21707866
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells.
De Santis E; Di Vito M; Perrone GA; Mari E; Osti M; De Antoni E; Coppola L; Tafani M; Carpi A; Russo MA
Biomed Pharmacother; 2013 Feb; 67(1):7-16. PubMed ID: 23089475
[TBL] [Abstract][Full Text] [Related]
3. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].
Cui XJ; Zhao HO; Su P; Chen J; Zhang RY; Pan Y; Ouyang XM; Liu J; Zhang JQ; Yang Y; Yang R; Ding L; Liu ZY
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):354-359. PubMed ID: 29783802
[No Abstract] [Full Text] [Related]
5. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction.
Egawa C; Miyoshi Y; Iwao K; Shiba E; Noguchi S
Oncology; 2001; 61(4):293-8. PubMed ID: 11721176
[TBL] [Abstract][Full Text] [Related]
6. Assessment of RET/PTC oncogene activation in thyroid nodules utilizing laser microdissection followed by nested RT-PCR.
Tallini G; Brandao G
Methods Mol Biol; 2005; 293():103-11. PubMed ID: 16028414
[TBL] [Abstract][Full Text] [Related]
7. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
8. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
[TBL] [Abstract][Full Text] [Related]
9. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.
Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H
J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566
[TBL] [Abstract][Full Text] [Related]
10. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
[TBL] [Abstract][Full Text] [Related]
11. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features.
Yavropoulou MP; Panagiotou G; Topouridou K; Karayannopoulou G; Koletsa T; Zarampoukas T; Goropoulos A; Chatzaki E; Yovos JG; Pazaitou-Panayiotou K
J Endocrinol Invest; 2017 Dec; 40(12):1327-1335. PubMed ID: 28589382
[TBL] [Abstract][Full Text] [Related]
13. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the ESR1 Gene and ESR Ratio (ESR1/ESR2) is Associated with a Worse Prognosis in Papillary Thyroid Carcinoma: The Impact of the Estrogen Receptor α/β Expression on Clinical Outcomes in Papillary Thyroid Carcinoma Patients.
Yi JW; Kim SJ; Kim JK; Seong CY; Yu HW; Chai YJ; Choi JY; Lee KE
Ann Surg Oncol; 2017 Nov; 24(12):3754-3762. PubMed ID: 28124274
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET/PTC 1-12 transcripts.
Imkamp F; von Wasielewski R; Musholt TJ; Musholt PB
J Surg Res; 2007 Dec; 143(2):350-63. PubMed ID: 17655865
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
[TBL] [Abstract][Full Text] [Related]
17. Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma.
Liu YM; Ying SP; Huang YR; Pan Y; Chen WJ; Ni LQ; Xu JY; Shen QY; Liang Y
World J Surg Oncol; 2016 Feb; 14(1):30. PubMed ID: 26846782
[TBL] [Abstract][Full Text] [Related]
18. Is the PIK3CA gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma?
Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Dedecjus M; Lewinski A
Neuro Endocrinol Lett; 2011; 32(1):59-63. PubMed ID: 21407159
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.
Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R
Thyroid; 2011 Mar; 21(3):267-77. PubMed ID: 21323588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
